Tvardi Therapeutics (TVRD) EBITDA (2013 - 2026)
Tvardi Therapeutics (TVRD) posted EBITDA of -$6.61 million for Q2 2026, compared with -$8.85 million a year earlier.
Powered by 
Analysis
Tvardi Therapeutics (TVRD) EBITDA (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA at Tvardi Therapeutics was -$27.11 million; for FY2025, it came in at -$26.65 million.
- In prior years, Tvardi Therapeutics' EBITDA was -$28.01 million in FY2024, -$121.24 million in FY2023, -$87.29 million in FY2022 and -$88.84 million in FY2021.
- Quarterly EBITDA has run from a low of -$33.46 million in Q4 2021 to a high of -$1.06 million in Q3 2021 over five years.
- According to Business Quant data, EBITDA for the three prior quarters was -$7.03 million (Q1 2026), -$7.56 million (Q4 2025) and -$5.91 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 13.33 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 7.37 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Tvardi Therapeutics | 12.48 Mn | -95.62 Mn | - | -6.61 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.61 Mn |
| Mar 31, 2026 | -7.03 Mn |
| Dec 31, 2025 | -7.56 Mn |
| Sep 30, 2025 | -5.91 Mn |
| Jun 30, 2025 | -8.85 Mn |
| Mar 31, 2025 | -4.33 Mn |
| Dec 31, 2024 | -10.78 Mn |
| Sep 30, 2024 | -5.65 Mn |
| Jun 30, 2024 | -7.18 Mn |
| Mar 31, 2024 | -29.62 Mn |
| Dec 31, 2023 | -32.53 Mn |
| Sep 30, 2023 | -28.84 Mn |
| Jun 30, 2023 | -32.28 Mn |
| Mar 31, 2023 | -27.59 Mn |
| Dec 31, 2022 | -31.25 Mn |
| Sep 30, 2022 | -23.78 Mn |
| Jun 30, 2022 | -4.41 Mn |
| Mar 31, 2022 | -27.85 Mn |
| Dec 31, 2021 | -33.46 Mn |
| Sep 30, 2021 | -1.06 Mn |
API Access
Tvardi Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=TVRD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "TVRD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=TVRD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();